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Abstract
Introduction: The objectives of the study were to evaluate the health system effectiveness of ANC for the delivery of a dose
of IPTp and an ITN to women attending ANC during eligible gestation, and to identify the predictors of systems
effectiveness.
Methods: A cross sectional study was undertaken in 10 health facilities including structured non-participant observations of
the ANC process for 780 pregnant women followed by exit interviews. The proportion of pregnant women receiving a dose
of IPTp-SP and an ITN was assessed. Predictors of each ineffective intermediate process were identified using multivariable
logistic regression.
Results: Overall, 0% and 24.5% of pregnant women of eligible gestation on the first visit to ANC received a dose of IPTp-SP
by DOT at the district and community levels respectively. Ineffective intermediate processes were ‘given IPTp-SP at the ANC’
63.9% and 74.0% (95% CI 62.0, 83.3), and ‘given IPTp-SP by DOT’ 0% and 34.3% (95% CI 10.5, 69.8), at district and
community levels, respectively. Delivery of ITNs was effective where they were in stock; however stock-outs were a problem.
Predictors of receiving IPTp-SP at the district level were 4 to 6 months gestation, not reporting symptoms of malaria at ANC
visit and the amount of money spent during the visit. At the community level, the predictors were 4 to 6 months gestation,
maternal education below primary level, routine ANC visit (not for an illness), palpation of the abdomen, and expenditure of
money in ANC.
Conclusion: In Segou District, the delivery of IPTp-SP was ineffective; whilst ITN delivery was effective if ITNs were in stock.
Predictors of receiving IPTp-SP at the district and community levels included gestational age, the amount of expenditure
during the ANC visit and no illness.
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Introduction
Malaria in pregnancy due to Plasmodium falciparum is associated
with maternal anaemia and low birth weight [1,2]. Low birth
weight due to malaria is preventable with intermittent preventive
treatment with sulphadoxine-pyrimethamine (IPTp-SP) [3,4].
IPTp-SP and insecticide treated nets (ITNs) are the currently
recommended tools for prevention of malaria in pregnancy in sub-
Saharan Africa (SSA)[5]. IPTp-SP is delivered to pregnant women
primarily through antenatal clinics (ANC), and ITNs are delivered
through ANC together with a variety of other systems. Based on
the findings of a randomised controlled trial in 2001[6], WHO
now recommend focussed ANC (fANC) [7]. As part of fANC it is
recommended that a pregnant woman visits ANC four times and
during these visits receive a number of interventions. These
interventions aim to identify risk factors and provide prevention
against the major infections causing poor outcomes in pregnancy.
In areas of stable malaria transmission, until October 2012 WHO
recommended that pregnant women were given 2–3 courses of
IPTp-SP after the onset of foetal movement with each course at
least one month apart [8]. New WHO guidelines now recommend
a dose of IPTp-SP at each scheduled visit beginning as early as
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possible in the second trimester, and with each dose at least one
month apart [9].
Despite one to two decades of implementation of IPTp-SP and
ITNs within national programmes in SSA, coverage of both of
these essential tools for protecting pregnant women are still low
[10,11]. As attendance at ANC at least once is high in many
countries of SSA [12,13] explanations are required as to the
reason for the differences in these estimates. The most recent
national level data for Mali estimated that 6.0% of pregnant
women received at least one dose of SP during an ANC visit, and
4.0% received 2 doses while 71% of women attended ANC at least
once and 63% attended twice [14]. Disparities across socio-
economic quintiles of receipt of SP during an ANC visit were
extremely high, as were attendance at ANC. This same survey
estimated that 28.9% of pregnant women slept under an ITN the
previous night. It is important therefore to understand the reasons
that women who attend ANC do not receive IPTp-SP, so that
interventions can be designed to target specific processes and to
increase the effectiveness of the health system to deliver this
efficacious intervention.
There have been a multitude of studies on the delivery of ITNs
through the public and private sectors, through continuous and
campaign delivery strategies, and on their use by target groups.
However, despite delivery of ITNs through ANC being the
primary continuous delivery strategy recommended by Roll Back
Malaria (RBM) [15], there is very little evidence of the
effectiveness of this delivery strategy. Studies have evaluated the
effectiveness of delivery of ITNs through ANC via voucher
schemes where the voucher subsidy is delivered in ANC and the
ITN in the private retail sector [16,17] but to our knowledge there
have been no evaluations of the effectiveness of the direct delivery
of ITNs themselves, through ANC.
The objectives of the study were to evaluate the health system
effectiveness of ANC for delivering a dose of IPTp-SP and an ITN
for women attending during eligible gestation as defined by the




The study was approved by the ethics committees of the Faculty
of Medicine, Pharmacy, and Odonto-stomatology, University of
Bamako, the London School of Hygiene and Tropical Medicine,
and the Liverpool School of Tropical Medicine. Health workers
gave signed consent at the initial meeting for structured
questionnaires and for structured observations. Pregnant women
gave signed consent for observations and exit interviews immedi-
ately prior to beginning the ANC process.
Study Site
The study was conducted in Segou region located 240
kilometers East of Bamako in Mali. The region is composed of 7
districts including the district of Segou where the study took place.
Segou District has a total population of 448,552 projected from
the 1998 census, with more than 60% of this population living in
rural areas. The climate of Segou is typical of the Sahel with an
average annual precipitation of 400 mm, with a wet season of
about three months (July–September) corresponding to the highest
malaria transmission period [18]. There is also a ‘cold’ dry season
(November–February) and a hot dry season (March–May/June)
Malaria in Segou Region is seasonal ranging from holo-endemic in
the southern part of the district and meso-endemic to the north.
The district has a total of 29 functioning health structures
comprising 1 hospital, 1 district level health facility (Centre de sante´ de
reference), and 27 community health centres (CSComs). At the time
of the study there were 8 non-functional CSComs. The hospital
serves as the regional referral centre and the Centre de Sante´ de
Reference (CSRef) for district level referrals. The CSComs are
situated between 5 km and 150 km from the CSRef. ANC services
are available Monday to Friday (8.00 am–5.00 pm) in Segou
District, but attendance varies by day of the week, with highest
attendance often linked to market days in the closest town. Since
the early 1980s a health sector reform programme facilitated the
development of community-financed health centres, in a move
away from a highly centralised urban bias in the health system.
These community-financed health centres rely on cost recovery for
the financing of most wage and non-wage recurrent costs, rather
than being government financed. This means that a limited
number of health staff are government funded.
Study Design and Data Collection
A cross sectional observational study was conducted in 10 health
facilities of Segou District. A dual frame sampling scheme was used
to purposively select the CSRef and a representative sample of
CSComs [19]. The CSRef was purposively selected as this serves
as the referral centre for the district, thus sharing the total
population of the district cross the CSComs. A further 9 health
facilities were randomly selected using probability proportional to
size from the composite list of health facilities.
Structured non-participant observations of 780 ANC visits were
undertaken between 2nd October and 26th November 2009. The
sample size was calculated using a standard method for health
facility surveys to estimate proportion of women with specific
service delivery endpoints [19]. The endpoints estimated were the
proportion of women that were given a dose of IPTp-SP on the
day of the visit, the proportion who were given SP by DOT, and
the proportion that were given an ITN. A total of 305 women
were needed to achieve a 5.5% precision, assuming the prevalence
of the specified endpoints is 40%. The sample size was increased in
order to enable the assessment of predictors of a range of processes
in the delivery of IPTp-SP and ITNs, this was done by
hypothetically estimating the proportion of pregnant women
attending ANC who would be offered IPTp-SP, the proportion
who would take the IPTp-SP when offered and the proportion
who would attend a second time and therefore have the possibility
of receiving a second dose. Based upon the catchment population
of the CSRef being the total population of Segou District and
upon the operational feasibility, one third of the sample was
collected from the CSRef, with the remaining two thirds from the
9 CSComs proportional to their catchment population according
to district records.
After gaining the consent of the head of each health facility, a
meeting was held with all staff to inform them of the study and to
collect background information from each health worker using a
structured questionnaire. Written consent to be observed was
obtained from health workers at this point. Five fieldworkers and
three supervisors conducted the observations and interviews by
approaching a woman as she entered the health facility, they then
introduced the study, gained the consent of the woman, observed
her ANC visit, and interviewed her on exit. On completion of the
process with the first woman they then approached the next
woman to enter the facility and repeated the process. The facility
observation schedule was based upon local market days, and
numbers of observations required at each facility. Facilities were
visited by the study team mainly on the busiest ANC day,
Delivery of IPTp-SP and ITNs in Mali
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coinciding with local market day. Each facility was visited by the
team until the required sample size was achieved.
Fieldworkers followed pregnant women from their entry to the
health facility until their completion of the visit including various
scenarios amongst registration, health education, history and vital
signs, consultation, prevention of mother to child transmission of
HIV (PMTCT), laboratory, post-laboratory consultation and
dispensary. During these observations, fieldworkers used a
structured checklist to record actions, and communications
between the health provider and pregnant woman. An exit
interview was conducted with the woman when ready to leave the
facility with direct questions on the events during the ANC visit,
observation of drugs received, and knowledge of the woman on
leaving the facility. Interviews were conducted in Bambara which
is the most predominant local language in Segou District.
Several different types of information were collected during the
observations which included responses of pregnant women to a
question by a fieldworker, responses of pregnant women to
questions from a health worker during the ANC visit, actions of
the pregnant women or the health worker observed by the
fieldworker, communications heard by a fieldworker during
observations and written information or data observed by a
fieldworker.
Health facility audits were undertaken at each of the ten health
facilities to assess the context within which ANC is delivered
including departmental structure of the facility, size in terms of
ANC attendance, numbers cadres of staff, and source of funding.
Study Definitions
A health system effectiveness algorithm was developed based
upon the WHO and national policy documents on IPTp-SP and
delivery of ITNs through ANC (Figure 1) which were in place at
the time of data collection. Women should be given IPTp-SP twice
during pregnancy in the second and third trimesters with the first
dose after quickening and each dose at least one month apart [20].
According to the Malian national policy at the time of the study,
IPTp-SP should be given free of charge, but should not be given to
women in their ninth month of pregnancy [21]. Each of the two
doses of IPTp-SP consists of 3 tablets of SP, each containing
500 mg sulpha drug and 25 mg pyrimethamine and should be
taken in the facility by directly observed treatment (DOT) by the
health provider.
The intermediate processes required for effective delivery of
IPTp-SP per policy were therefore defined as: Intermediate
process 1: attend ANC consultation between 4 and 8 months
pregnant; Intermediate process 2: be given any SP; Intermediate
process 3: be given 3 tablets of SP; Intermediate process 4: be
given SP by DOT; Intermediate process 5: told when to return for
the next visit; and Intermediate process 6 told to return in 4 to 5
weeks. The data source for each of these processes was observation
of the ANC visit. In order to include the situation where a woman
was not given IPTp-SP by DOT but may still have been given and
taken SP, in a second analysis process 4 was defined as took the SP
by DOT or left the facility with 3 tablets of SP and was able to
report correctly how they would be taken. The data for these
processes was obtained at exit interview. As the policy is that 2
doses of IPTp-SP should be given, full effectiveness requires that
those pregnant women for whom IPTp-SP is successfully delivered
once, should attend ANC a second time and progress effectively a
second time through the first 4 defined processes. It is important to
note that pregnant women with symptoms of malaria were not
excluded from the effectiveness denominator as there is no
direction on this in the national guidelines and the diagnosis of
malaria in pregnancy within these health facilities needed more
study. The case management of malaria in pregnancy in these
health facilities will be presented elsewhere.
According to the national policy, every pregnant woman should
be given an ITN on her first visit to ANC [21]. The health systems
effectiveness algorithm for ITNs as included in Figure 1 is
relatively simple consisting of just 3 processes: Process 1 attend
ANC; Process 2 be offered an ITN; and Process 3 take the ITN.
Intermediate processes for systems effectiveness of the delivery
of IPTp-SP and ITNs were described as ineffective if less that 80%
of pregnant women were reached by the process [17]. Cumulative
systems effectiveness represents successful coverage of women for
each of the intermediate processes up to the designated point in
the effectiveness algorithm.
Analyses
Data were double entered and validated using EpiData version
3.1 [22], and Stata 11.0 [23] was used for data processing and
analysis. Analyses accounted for the survey design, adjusting for
clustering within health facilities. Sample weights for observations
were estimated based upon the sampling probability of each
selected health facility [19]. Analyses were stratified by CSRef and
collated CSCom as we hypothesised that the systems effectiveness
and the predictors of the intermediate processes involved in
delivery of IPTp-SP would differ at these different levels of the
health system.
Two systems effectiveness analyses were undertaken for IPTp-
SP: 1) a cumulative analysis of the overall effectiveness of the
intermediate processes for women who reported during exit
interview that they were 4 to 8 months pregnant for their 1stand
for their 2nd visit to ANC, and 2) an assessment of the effectiveness
of each individual intermediate process for women 4 to 8 months
pregnant for their 1st, and 2nd visits to ANC. The effectiveness of
each intermediate process in the delivery system effectiveness
algorithm was calculated by estimating the proportion of women
who successfully reached each step from the previous step [17].
Two cumulative delivery system effectiveness estimates were
calculated 1) a ‘per policy’ estimate of receiving 3 tablets of SP
by directly observed therapy (DOT) on first, and second visits to
ANC; 2) a with or without DOT inclusive estimate of the
proportion of women either receiving 3 tablets of SP by DOT, or
leaving the health facility with 3 tablets of SP and able to report on
questioning that they would take all 3 tablets at one time. For
ITNs the cumulative effectiveness included only 3 steps which
were attend ANC (with no restrictions on gestation), offered an
ITN, and given an ITN during ANC consultation.
Principal components analysis (PCA) was used to create an asset
index [24,25] based upon household characteristics such as source
of drinking water, type of toilet facilities, and a range of household
assets. All assets were included in the PCA as binary variables [26].
The asset index was then used to construct socio-economic
quintiles from the poorest households through to the least poor.
This method has been validated in household surveys with
information on both assets and income or expenditure [27]. In this
study these socio-economic quintiles are not representative of the
population level, but are a relative score amongst women who
attend ANC in Segou District, and a greater proportion of
pregnant women from less poor households attend ANC in Mali
[28].
Potential predictors of intermediate processes for pregnant
women 4 to 8 months pregnant (for IPTp-SP) on their first visit to
ANC were assessed using a univariate (unadjusted) logistic
regression model. Categories of potential predictors included:
socio-demographic; pregnancy factors; health facility factors; and
3 types of process factors which were departments and time; illness
Delivery of IPTp-SP and ITNs in Mali
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or suspected illness; and payments. Individual potential predictors
within each of these categories were measured during the
structured observations by fieldworkers observing actions, listening
to communications, or observing written information (Table 1).
Potential predictors were analysed for those intermediate
processes that were found to be ineffective, that is for which less
than 80% of women who should have completed the process, did
so. These analyses were restricted to women 4 to 8 months
pregnant, but gestation was included as a potential predictor.
Adjusted Wald tests were used to assess the association between
each potential predictor and the outcome of each intermediate
process. Predictors with Odds Ratios (ORs) significant at the 10%
level (p-values,0.1) were included in multi-variable (adjusted)
logistic regression models for each intermediate process outcome
in order to determine which potential predictors remained
associated with each of the outcomes when adjusted for other
predictors. ORs were estimated rather than Relative Risk (RR)
due to clustering and stratification of the sample, and therefore our
outcomes not being truly representative of the district level
population. In the multi-variable models, predictors were consid-
ered significant at the 10% level at all stages of model building
except for the final model where p,0.05 was used [14].
The design effect (DE) and intra-cluster correlation coefficients
(ICC) were calculated for 6 systems effectiveness intermediate
processes defined in the health systems effectiveness algorithm
(Figure 1) for aggregated CSRef and CSComs, and for aggregated
CSComs alone. The design effect was calculated as the difference
between the variance based on the clusters used compared with a
modelled variance if a simple random sample was used. A design
effect of 1 means that variance is unaffected by clustering and is
equivalent to that of a simple random sample. An ICC of 0
equates to a DE of 1 where the variance is equivalent to that of a
simple random sample.
Results
Characteristics of the Health Facilities
The sample included 1 CSRef, 8 CSComs and 1 Dispensary for
ease of presentation we included the dispensary amongst the
CSComs in this paper (Table 2). Eight facilities had at least one
staff member funded by the government. Cadres of staff with
government salaries included: doctors, midwives, nurses, public
health nurses, health technicians, and auxillaries. The number of
ANC attendees during 2008 ranged from 165 in the Dispensary to
2,811 in the CSRef. The number of staff usually in ANC ranged
from 2 to 7. The CSRef and two of the CSComs had a functioning
laboratory, with malaria microscopy performed in the CSRef and
one of the CSComs. All facilities had a pharmacy with the
exception of one CSCom and the Dispensary. Numbers of
structured observations by facility are presented in Table 2.
There were no stock-outs of SP in any of the sampled health
facilities during the period of data collection. The CSRef and two
Figure 1. Systems effectiveness algorithm for IPTp-SP and ITNs.
doi:10.1371/journal.pone.0067520.g001
Delivery of IPTp-SP and ITNs in Mali
PLOS ONE | www.plosone.org 4 June 2013 | Volume 8 | Issue 6 | e67520
of the CSComs had a stock-out of ITNs during the data collection
period.
Characteristics of Health Workers
A median of 4 (range 1–10) health workers was interviewed per
facility, with a total of 68 across all 10 facilities. The health workers
were 32.4% male and 67.6% female, had a mean age of 34 (range
20–57) and were from 12 ethnic groups: 41.0% Bambara, 14.7%
Malinke, 11.8% Peuhl (Fulani), 10.0% Minianka, and less that
10.0% Senoufo, Bobo, Arabe, Bozo, Dogon, Maure, Sarakole and
Sonrhai. A total of 61.8% of health workers were from Segou
Province, 52.9% from Segou District, and 32.4% were from the
Table 1. Descriptions of the potential predictors included in the univariate analyses.
Indicator Description Source
Pregnant women socio-demographic
Age group Age 1
Marital status Single (incl. engaged), married, divorced 1
Education ‘Formal’ with primary lowest level 1
Ethnicity 6 named response categories+other 1
Religion 3 named response categories+other 1
Socio economic status Questions on a range of household assets 1
Pregnancy factors
Months pregnant On the day of the survey 1
Number of children Live children only 1
Visit number Number of visits to ANC including the current one 1
Health facility factors
Cadre of health worker in consultation Based on previous enrolment of health workers 3
Process factors:
1. departments and time
Morning consultation Consultation between 8 am and 12 pm 3
Palpation Palpation of the abdomen in ANC consultation 3
Prescribed rhesus test Prescribed during ANC consultation 4+/25
Total time spent in consultation From entry to completion of ANC consultation 3
Had HIV PMTCT consultation Entered the designated room and was seen by a health worker and/or HIV was discussed
during ANC
3
Given ITN in consultation Was offered and took an ITN 3
2. illness or suspected illness
Reason for visit Routine ANC visit alone, or also because of illness 1
Suggest a lab test during consultation Any lab test suggested during ANC consultation 4+/25
Prescribed syphilis test During ANC, or PMTCT consultations 4+/25
Report illness at consultation Any illness reported by the woman during consultation 2
Consult malaria Woman reports that she has malaria at consultation 2
Has symptoms of malaria Woman reports that she has malaria, fever, shivers, or chills at ANC 2
Woman reports symptoms of STI/UTI Woman reports vaginal discharge, dysuria or UTI at ANC 2
HIV in PMTCT Tested for HIV in PMTCT 2
3. payments
Pay for registration Any money paid in registration 3+/25
Pay for consultation Any money paid in consultation 3+/25
Pay for medicines Any money paid for medicines 1
Amount paid for medicines Total amount paid for medicines 1
Spent money on travel Any money spent on travel to and from the facility 1
Amount spent on travel Amount of money spent on travel to and from the facility 1
Money expenditure in the facility Any money spent in the facility during this visit 1
Total expenditure Total amount of money spent in the facility during this visit 1
Source Key.
1 = response of pregnant woman to a question by a fieldworker; 2 = response of pregnant woman to a question from a health worker; 3 = action observed by
fieldworker; 4 = heard by a fieldworker during observations; 5 =written information/data observed by fieldworker; PMTC, Prevention of Mother to Child Transmission;
ITN, Insecticide Treated Net; STI, sexual transmitted infection; UTI, Urinary Tract Infection; HIV, human immunodeficiency virus; ANC, Antenatal clinic;
doi:10.1371/journal.pone.0067520.t001
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town or village within which they were providing health care.
Nearly a quarter (23.5%) of those interviewed had worked in the
current health facility for less that 1 year, 23.5% for 1 to 3 years,
and 53.0% for more than 3 years. All health workers interviewed
support the care of pregnant women and 57.4% worked in ANC.
Amongst the ANC consultations observed, 47.7% were conducted
by a ‘matrone’ (an under qualified nurse), 35.4% by trainee/non-
permanent cadres (midwives or obstetric nurses), 10.4% by
qualified obstetric nurses (trained in nursing and obstetrics), and
6.5% by qualified midwives (not trained in nursing).
Characteristics of Pregnant Women
A total of 780 ANC visits were observed, and 770 pregnant
women interviewed on exiting the health facility. The population
of pregnant women attending ANC in the CSRef varied in several
indicators compared with those attending the CSComs (Table 3).
Women attending the CSRef were generally younger, had a
higher level of education, were more ethnically diverse, of higher
socio-economic status, had lesser number of children or were
primigravidae and were more likely to be attending ANC for a
routine visit together with an illness.
Systems Effectiveness of Delivery of IPTp-SP
The cumulative systems effectiveness for receiving one dose of
IPTp-SP by DOT (processes 1 to 4), for women attending CSRef
was 0% on their first visit to ANC and 2.1% on their second visit
(Figure 2). Amongst pregnant women attending CSComs for their
first ANC and second ANC visits 24.5% and 25.4% received
IPTp-SP by DOT, respectively (Table 4). For women on their
third visit to ANC the systems effectiveness of receiving one dose of
IPTp-SP by DOT for women attending the CSRef was 0% and
8.5% for women attending the CSComs.
Where the definition of systems effectiveness was broadened to
include both those women who received IPTp-SP by DOT, and
those who have 3 tablets on exiting the health facility and are able
to report correctly how to take them, then the systems effectiveness
was increased. For pregnant women attending the CSRef
cumulative systems effectiveness for processes 1 to 4 increased to
55.7% for those on their 1st visit, 45.8% for those on their 2nd visit,
and 37.9% for those on their third visit; for the CSComs 66.7% on
the 1st visit, 68.1% on the 2nd visit and 45.7% on the third visit.
These are likely to be overestimates as they assume that 100% of
pregnant women adhere to taking all 3 doses outside of the health
facility.
Estimating the intermediate process systems effectiveness in
delivery of one dose of IPTp-SP based upon the algorithm
presented in Figure 1, two intermediate processes in the delivery of
IPTp-SP per policy were ineffective which were 1) being given SP
in ANC, and 2) being given SP in ANC by DOT. Approximately
two thirds of pregnant women (63.9%) who were between 4 and 8
months pregnant when they attended the CSRef for their first
ANC visit were given SP, whilst three quarters of eligible pregnant
women (74.0%; 95% CI 62.0, 83.3) were given SP on their 1st visit
to the CSCom (Table 3). The majority of women at the CSRef
and CSComs who were given SP, correctly were given 3 tablets on
their first visit. Amongst pregnant women attending ANC and
receiving SP at the CSRef none were given the SP under DOT,
whilst amongst those attending a CSCom 34.3% (95% CI: 10.5,
69.8) were given the SP by DOT.
On completing ANC consultation, pregnant women on their 1st
and 2nd visits should be told that they need to return to ANC, and
they should be told when to return. The intermediate process of
being told to return was ineffective, with 23.5% and 4.5% of those
attending the CSRef, and 18.8% and 8.6% of those attending the
CSComs being told to return at the close of their 1st and 2nd visits,
respectively. For those on their 1st visits to both CSRef and the
CSComs who were told to return, the time within which they were
told to return was correct for greater than 80% in both categories
of facility, and therefore an effective intermediate process
according to the definition adopted for this study.
Systems Effectiveness of Delivery of ITNs
The CSRef did not have ITNs in stock during the period of data
collection, therefore none of the pregnant women attending the
CSRef for their ANC visit of any gestation were given an ITN
during the survey (Figure 3) and the health systems effectiveness
was 0%. Eight women reported that they were offered an ITN
even though there were stock-outs. The cumulative effectiveness of
delivery of ITNs through the CSComs for women of any gestation
on their 1st visit was 72.4%, and amongst those on their 2nd visit
5.6% (Table 4).
The systems effectiveness algorithm for delivery of ITNs used in
this study included only 3 intermediate processes the first of which,
attendance at ANC provided the denominator for the estimates of
other intermediate processes. For women attending ANC in the
Table 2. Characteristics of health facilities.
1 2 3 4 5 6 7 8 9 10
Level CSRef CSCom CSCom CSCom CSCom Dispensary CSCom CSCom CSCom CSCom
No. Staff in ANC 6 4 3 3 2 3 2 3 3 7
Have lab yes no no No No no yes no no yes
Have a pharmacy yes yes yes yes yes no no yes yes yes
ANC registrants1* 1,039 880 841 756 700 105 318 757 381 1,279
ANC attendees2* 2,811 1,871 1,938 1,642 1,349 165 637 1,302 714 1,885
Distance from CSRef
(Km)
– 5 50 45 120 15 10 150 20 5
No. Of observations 259 96 43 60 88 64 48 44 47 29
1attending for the first time during the current pregnancy;
2attending for the first time or multiple times during the current pregnancy; *during 2008.
CSRef; Reference Health Centre; CSCom, Community Health Centre; ANC, antenatal clinic; Km, kilometre;
No., number.
doi:10.1371/journal.pone.0067520.t002
Delivery of IPTp-SP and ITNs in Mali
PLOS ONE | www.plosone.org 6 June 2013 | Volume 8 | Issue 6 | e67520
CSComs the offer of an ITN by health workers was just below the
defined effectiveness target of 80% (Table 5). The uptake of ITNs
amongst those women offered it on a 1st ANC visit was effective in
this group of women, 91.2%.
Predictors of being given SP
In the unadjusted logistic regression analyses for women
attending the CSRef predictors of being given SP included 2
pregnancy related and 9 process related factors (Table 6).
In the multivariate analysis only three predictors remained
significantly associated with the systems effectiveness of being
given SP. They were gestational age, had no symptoms of malaria,
and the total expenditure in the health facility. A final model
including these 3 indicators alone found that women who attended
ANC at the CSRef were more likely to be given SP if the total
expenditure they reported during the visit to ANC was between
CFA 500 to 999 (adjusted OR 3.1 95% CI 1.4, 7.2; p = 0.006)
compared to CFA,500 spent; and less likely to receive IPTp-SP if
they were 7 to 8 months pregnant (adjusted OR 0.23 95% CI 0.11,
0.5; p = 0.002) than if they were 4 to 6 months pregnant. Women
were less likely to receive IPTp-SP if they reported symptoms of
malaria during ANC consultation (adjusted OR 0.27 95% CI
0.09, 0.84; p = 0.02).
The predictors of being given SP in the CSComs differed from
those of the CSRef (Table 5). In the univariate analyses, there was
1 socio-demographic, 2 pregnancy related and 5 process predictors
of being given SP in a CSCom.
When adjusted for other univariate predictors, those multivar-
iate predictors remaining significant were the education level of
the pregnant woman, gestational age, the reason for the visit,
palpation, and any expenditure during the visit. A final model
(data not shown) including these 5 indicators showed that women
who attended ANC at the CSComs were more likely to be given
SP if they were palpated in ANC consultation (adjusted OR 1.77
95% CI 1.0, 3.12; p = 0.05) or had any expenditure in the health
facility during the visit (adjusted OR 2.27 95% CI 0.99, 5.2;
p = 0.05); and less likely to be given IPTp-SP if they were educated
above primary level (adjusted OR 0.28 95% CI 0.18, 0.45;
p = 0.0001) were 7 to 8 months pregnant (adjusted OR 0.25 95%
CI 0.11, 0.6; p = 0.005), or attended ANC for a routine visit and
because they were ill (adjusted OR 0.4 95% CI 0.17,0.97;
p = 0.04).
Predictors of being given SP by DOT
Women who attended ANC at the CSRef were not given SP by
DOT. Amongst pregnant women who were given SP at ANC in a
CSComs, unadjusted predictors of being given SP by DOT
included 1 socio-demographic factor, and 5 process factors
(Table 7).
When adjusted for other univariate predictors, the only
multivariate predictors remaining significant were socio-economic
group of the pregnant woman, and the total expenditure in the
health facility on the day of the visit. In the final model (data not
shown), pregnant women were more likely to be given SP by DOT
if they spent 500 to 999CFA (adjusted OR 9.87 95% CI 1.28,
75.71; p = 0.01) or$1,000 CFA (adjusted OR 12.17 95% CI 3.14,
47.16; p = 0.01) than if they spent less than 500CFA.
Predictors of Receiving an ITN
Women who attended ANC at the CSRef for their first ANC
visit were not offered and were not given an ITN as there was a
stock-out at the time of the study. Amongst women attending ANC
at the CSComs there was 1 socio-demographic, and 7 process
Table 3. Characteristics of pregnant women attending the
CSRef and the CSComs.
Characteristic CSRef (N=259) CSComs (N=521)
n % n % p
Age group 0.04
,20 67 25.9 121 21.9
20–29 135 52.1 247 47.8
30–39 51 19.7 139 27.4
40–49 6 2.3 14 2.9
Education 0.004
None 90 34.7 292 56.3
Primary 106 40.9 198 39.2
Primary + 63 24.3 31 4.5
Marital status 0.31
Married 229 89.1 469 92.5
Single 27 10.5 44 7.3
Divorced 1 0.4 1 0.2
Ethnic group 0.01
Bambara 100 38.6 271 52.9
Peuhl (Fulani) 40 15.4 73 15.4
Other 119 45.9 177 31.7
Religion 0.44
Muslim 253 98.4 499 96.9
Christian 4 1.6 10 1.8
Other 0 – 7 1.3
SES group 0.0002
1 poorest 6 2.3 147 28.2
2 very poor 19 7.4 134 27.4
3 poor 37 14.5 118 24.8
4 less poor 90 35.2 61 12.0




0 75 29.0 119 21.6
1 73 28.2 98 18.9
2–4 85 32.8 236 45.5
5+ 26 10.0 68 14.1
Gestational age 0.16
1–3 months 39 16.9 56 11.6
4–6 months 100 43.3 205 43.3
7–9 months 92 39.8 199 45.1
ANC Visit number 0.06
1 110 42.5 280 51.2
















Reason for visit 0.006
Routine ANC 188 72.6 417 80.5
Routine ANC+ill 71 27.4 98 19.5
Notes:
Primary+= any level above primary (secondary, tertiary etc).
CSRef, Reference Health Centre; CSCom, Community Health Centre; n, number
of events; N, sample size; ANC, Antenatal clinic;
doi:10.1371/journal.pone.0067520.t003
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factors that were predictive of being offered an ITN in ANC in
univariate analyses (Table 8).
When adjusted for other univariate predictors, those multivar-
iate predictors remaining significant were the socio-economic
status of the pregnant woman’s household, symptoms of malaria,
palpation, paying money during consultation, and the total
expenditure at the health facility. A final model (data not shown)
including these adjusted predictors of being offered an ITN in
ANC showed that pregnant women were more likely to be offered
an ITN if they were palpated (adjusted OR 5.0 95% CI 1.3, 19.5
p= 0.03); and if the total expenditure in the health facility was
$CFA1,000 (adjusted OR 10.3 95% CI 2.7,39.5; p = 0.004). They
were less likely to be offered an ITN if they were from the 4th
socio-economic quintile (adjusted OR 0.08 95%CI 0.04, 0.16),
that is less poor households; and if they paid money for
consultation (adjusted OR 0.05 95% CI 0.007, 0.41; p = 0.01).
Design Effect and Intra-cluster Correlation
The within cluster correlation was low for being told to return
for their next visit in 4 to 5 weeks amongst pregnant women in the
CSComs who were told to return at all (DE 0.58, ICC 20.007),
for this indicator the sample therefore resembled that of a simple
random sample (Table 9). For indicators of relatively effective
processes such as being given 3 tablets of SP amongst those given
any SP (97.1%; DE 1.49, ICC 0.009), being told to take 3 tablets
(93.4%; DE 1.07, ICC 0.001) and being able to report on exit that
they would take 3 tablets at one time, amongst those with 3 tablets
(98.5% DE 0.83, ICC 20.003) as would be expected due to the
high coverage across facilities clustering within health facilities was
low. Amongst the ineffective processes being given SP by DOT
was found to cluster more by health facility (33.1% DE 21.11, ICC
0.353) than receiving any SP during consultation (68.0% DE 2.86,
ICC 0.033) and being told when to return for the next dose (14.8%
DE 2.53, ICC 0.027).
The design effect and intra-cluster variation were generally
higher for the CSRef plus CSComs than for the CSComs alone
but the pattern was similar across the indicators of intermediate
process effectiveness.
Discussion
This cross sectional health facility survey enabled an in-depth
investigation of the ANC experience and interactions with health
providers of pregnant women attending ANC at two levels of the
health system in Segou District. Using a structured checklist it was
possible to quantify these processes and interactions for all women
attending ANC on the day of the survey. This quantification of
processes plus information collected on characteristics of pregnant
women and the health facilities enabled an assessment of a wide
range of possible predictors of the effectiveness of these delivery
processes.
Delivery of IPTp-SP by DOT was found to be ineffective
amongst pregnant women attending ANC for their first or second
visit during the current pregnancy, who were of eligible gestation
according to national policy. When the requirement of DOT was
excluded from the definition of effective delivery of IPTp-SP in a
second analysis (a pregnant woman was given the correct number
of tablets and had knowledge on how to take them, thus giving the
opportunity for her to take an effective dose) the proportion of
pregnant women being given a course of IPTp-SP (first or second
dose) was higher than for delivery by DOT alone (55.6% and
66.7%) for the CSRef and CSComs respectively, close to the
previous Abuja target (60% of 2-dose in 2005) [29], and way below
the 100% target for universal coverage [30]. In addition, this was
the maximum effectiveness possible as it assumed that 100% of
women who had the tablets and the knowledge complied with the
instructions given. In practice, this is unlikely to be the case and
these are likely to be substantial overestimates. We are not aware,
however of any empirical data on the proportion of women who,
given tablets of SP for IPTp to take at home, comply with this
preventive treatment regimen. Although there is a wealth of data
available on the lack of adherence to anti-malarial treatment
regimens in the household, as this data is primarily for treatment
of symptomatic malaria cases, it is not appropriate to draw
parallels here.
After determining that delivery of IPTp-SP was ineffective
overall, we were able to identify the specific ineffective processes
through an intermediate process analysis. The first of these
Figure 2. Cumulative effectiveness of delivery of IPTp during 1st ANC visit by women 4 to 8 months pregnant. Intermediate process
1 = attend ANC consultation; Intermediate process 2 =given SP during ANC consultation; Intermediate process 3 = given 3 tablets SP; Intermediate
process 4 = take SP by DOT (A); or take SP by DOT or have 3 tablets on exit and can report correctly how they will be taken (B).
doi:10.1371/journal.pone.0067520.g002
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ineffective processes was that of a pregnant woman being given
any SP in ANC consultation. The adjusted predictors of being
given SP, with the exception of being second or third trimester,
differed between the CSRef and the CSComs. Visit number did
not remain predictive of being given SP in the CSRef after
adjusting for other potential predictors. The relationship between
number of visits and being given SP may have been influenced by
attendance of women at more than one health facility. Although
we did not assess parity directly we found number of children was
not a predictor of being given SP in this setting. Parity has
previously been reported as a predictor of receiving IPTp-SP
[31,32]. The finding from other studies which were population
based rather than amongst attendees at health facilities, may have
been due to lack of adjustment for factors influencing attendance
at ANC. More specifically the findings from these studies may
have been confounded by earlier attendance at ANC by
primigravidae and a greater proportion of primigravidae attending
ANC twice.
In the CSRef, having symptoms of malaria, including fever,
shivers, or chills reported by the pregnant woman, reduced the
odds of being given SP. This may account for visit number not
being predictive of being given SP in this health facility. According
to the national policy at the time of this study pregnant women
with malaria should be treated with quinine, and therefore not
being given IPTp-SP was appropriate. Perhaps the most important
factor to note here is that as mentioned in the methods, treatment
of pregnant women for malaria was not accounted for in the
indicator for being given a dose of IPTp-SP used in this study, as
we based the analysis on national guidelines which are in-line with
the global indicator for assessing coverage with IPTp-SP as
measured through the DHS, MIS and other national household
surveys. These findings suggest that in Segou District it was
important to take pregnant women treated for malaria out of the
denominator when assessing effectiveness of delivery of IPTp-SP.
According to the structure of the health system in Mali, the main
role of the CSRef within the district is to function as a referral
centre for patients from the CSComs [33]. It is not surprising
therefore that a high proportion of pregnant women attending
ANC at the CSRef complained of an illness at the time of their
routine ANC attendance (20%). However, the proportion of
pregnant women attending ANC with symptoms of malaria in the
CSComs was also quite high at approximately 13%. There is a
need to assess whether adjustment to the denominator of the
delivery and coverage indicator for IPTp-SP is necessary in other
settings, and in order to do this the proportion of pregnant women
accessing ANC who are treated for malaria should be estimated.
Table 4. Cumulative and intermediate process effectiveness of delivery of IPTp-SP amongst those 4 to 8 months pregnant.
1st visit 2nd visit
CSRef CSCom CSRef CSCom
Intermed Cum Intermed Cum Intermed Cum Intermed Cum
n % n % (95% CI) p n % n % 95% CI p
With DOT
Attended ANC 61 189 48 109
Given SP during consultation 39 63.9 63.9 141 74.0
(62.0, 83.3)
0.09 74.0 25 52.1 52.1 81 72.4
(49.6,87.5)
0.07 72.4
Given 3 tablets 39 100.0 63.9 136 96.5
(89.8, 98.8)
0.59 71.4 25 100 52.1 79 97.1
(88.5,99.3)
0.80 70.4
Took SP by DOT 0 0 0 55 34. 3
(10.5, 69.8)




Attended ANC 61 189 48 109
Given SP during consultation 39 63.9 63.9 141 74.0
(62.0, 83.3)
0.09 74.0 25 52.1 52.1 81 72.4
(49.6,87.5)
0.07 72.4
Given 3 tablets 39 100.0 63.9 136 96.5
(89.8, 98.8)
0.59 71.4 25 100 52.1 79 97.1
(88.5,99.3)
0.59 70.4
Has SP tablets on exit 35 89.7 57.4 74 59.5
(27.4, 85.1)
0.01 44.3 24 96 50.0 45 60.7 (26.9,
86.6)
0.004 42.7
Report will take 3 tablets 34 97.1 55.7 72 97.0
(90.3, 99.1)
0.90 42.0 21 87.5 43.8 45 100 0.004 42.7
With or without DOT inclusive
Report will take 3 tablets & has
tablets
on exit or took SP by DOT
34 87.2 55.7 127 91.9
(82.2, 96.5)
0.23 66.7 22 88 45.8 76 96.7 (83.9,
99.4)
0.08 68.1
Told when to return for next dose 8 23.5 13.1 27 18.8
(9.3, 34.5)
0.44 12.3 1




CSRef, Reference Health Centre; CSCom, Community Health Centre; n, number of events; CI, Confidence Interval; Cum, cumulative process; Intermed, Intermediate
process; DOT, Direct Observed Treatment; ANC, Antenatal Clinic; SP, Sulphadoxine-pyrimethamine.
doi:10.1371/journal.pone.0067520.t004
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The proportion of pregnant women treated for malaria upon
attendance at ANC is not currently included in the standard
survey tool for the DHS or MIS (http://www.measuredhs.com/
What-We-Do/Survey-Types/DHS-Questionnaires.cfm; http://
www.measuredhs.com/What-We-Do/Survey-Types/MIS.cfm )
however the proportion of pregnant women who took any anti-
malarial drug is often included. More work is needed to
understand the relationship between taking anti-malarials for
treatment during pregnancy, receiving the required number of
doses of IPTp-SP, and how to combine or interpret both
indicators.
A further predictor of being given SP in the CSRef after
adjusting for other potential predictors was having paid at least
CFA 500 whilst in the facility. According to the national policy
IPTp-SP should be delivered to eligible pregnant women free of
charge [21], however on first visit to ANC there is a fee of CFA
500 for registration. In the CSRef 93% of first visit pregnant
women paid CFA500 at registration, 8% of pregnant women on
their second visit also paid this fee and 1% of women on their 3rd
visit. In addition to registration fees all women attending the
CSRef paid CFA 300 for ANC consultation. Both paying CFA
500 in registration and paying for consultation were perfectly
predictive of getting SP.
For pregnant women attending the CSComs, educational level
together with gestation and visit number was predictive of their
being given IPTp-SP. Higher levels of education have been
reported as predictive of receiving IPTp-SP [34,35]; however these
studies were population based cross sectional surveys, where this
finding may be confounded by increased attendance at ANC
amongst those with higher education levels. In such surveys
although predictors are adjusted for the influence of other
potential predictors these analyses are usually conducted with a
denominator of all pregnant or recently pregnant women sampled,
rather than amongst women who attended ANC. This access
factor may also contribute to parity being reported as a predictor
of being given IPTp-SP in population based studies, as mentioned
above. It is important in future studies that access to health services
and delivery of interventions are disaggregated in predictor
analyses.
Unlike the CSRef, paying for registration and paying for
consultation were not predictive of getting SP at CSComs; though
having spent any money during the visit was a predictor. These
findings suggest differences in the way payments are made by
women for different procedures and drugs within the CSRef and
the CSComs which may in turn relate to the government rather
than community funding of the CSRef. However, it is clear that if
we are to improve delivery of IPTp-SP in an equitable manner
then these cost issues need addressing so that delivery is truly free
at all levels of the health system. This predictor offers direct action
for a solution to systems ineffectiveness where as other predictors
such as palpation do not provide a clear course of action as there
are many reasons why this should be predictive of being given
IPTp-SP and qualitative data would be useful to provide clarity.
The second ineffective process was giving IPTp-SP by DOT.
Delivery of IPTp-SP by DOT was not generally practised in the
CSRef. Just one pregnant woman was given a dose of IPTp-SP as
directed by the national policy guidelines when attending the
CSRef and just one third of those who attended the CSComs were
given IPTp-SP by DOT. Amongst pregnant women who were
given IPTp-SP in ANC it is not clear why the total amount of
money spent in the health facility was a predictor of DOT after
adjusting for other potential predictors. This finding suggests that
additional approaches are needed to gain a deeper understanding
of the processes within health facilities and factors that influence
giving treatment by DOT. It has previously been shown that
giving IPTp-SP by DOT is influenced by the availability of clean
drinking water [36]. Such factors are not easily captured using
Figure 3. Cumulative effectiveness of delivery of ITNs during
1st ANC visit by women of any gestation. Intermediate process
1 = attend ANC; Intermediate process 2 =offered ITN during ANC
consultation; Intermediate process 3 = take ITN.
doi:10.1371/journal.pone.0067520.g003
Table 5. Cumulative and intermediate process effectiveness of delivery of ITNs amongst pregnant women of any gestation.
1st visit 2nd visit
CSRef CSCom CSRef CSCom
Intermed Cum Intermed Cum Intermed Cum Intermed Cum
n % n
%
(95% CI) p n % n % 95% CI p
Attended ANC 110 280 66 133
Offered ITN during
consultation
8 7.3 7.3 232 79.4
(55.9, 92.2)
,0.0001 79.4 0 0 0 10 6.5 (1.8, 21.1) – 6.5
Given ITN during
consultation
0 0 0 211 91.2
(63.1,98.4)
– 72.4 0 0 0 10 86.2 (1.0, 100) – 5.6
Notes:
CSRef, Reference Health Centre; CSCom, Community Health Centre; n, number of events; CI, Confidence Interval; ANC, Antenatal Clinic; ITN, Insecticide Treated Net.
Intermed = Intermediate process effectiveness; Cum= cumulative effectiveness.
doi:10.1371/journal.pone.0067520.t005
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Table 6. Unadjusted and adjusted predictors of receiving SP during consultation.
Potential
predictors CSRef CSCom
Unadjusted Adjusted Unadjusted Adjusted




None 55 1.0 0.31 199 1.0 0.02 1.0 ,0.001
Primary 74 0.93 (0.46, 1.88) 136 1.42 (0.64, 3.15) 1.56 (0.57, 4.26)
Primary + 37 1.70 (0.73, 3.93) 19 0.37 (0.13, 1.03) 0.25 (0.16, 0.41)
Pregnant woman
Months pregnant
4–6 months 100 1.0 ,0.001 1.0 0.002 205 1.0 0.003 1.0 0.03
7–8months 66 0.24 (0.12, 0.48) 0.24 (0.09, 0.60) 149 0.25 (0.12, 0.56) 0.34 (0.13, 0.88)
Visit number
3 61 1.0 ,0.001 1.0 0.22 54 1.0 0.04 1.0 0.26
2 48 6.65 (2.92, 15.15) 2.14 (0.29, 16.15) 109 4.38 (1.54, 12.41) 2.05 (0.66, 6.33)




162 1.04 (1.01, 1.08) 0.03 1.04 (0.99, 1.08) 0.11 348 0.99 (0.98, 1.00) 0.17
Went to PMTCT
No 150 1.0 0.02 1.0 0.16 313 1.0 0.92
Yes 16 4.03 (1.24, 13.08) 2.65 (0.68,10.27) 41 0.95 (0.32, 2.85)
Reason for visit
ANC 121 1.0 0.009 1.0 0.13 290 1.0 0.06 1.0 0.04
ANC & illness 45 0.37 (0.18, 0.78) 0.49 (0.20, 1.22) 63 0.52 (0.26, 1.03) 0.39 (0.16, 0.97)
Symptoms
malaria
No 145 1.0 0.04 1.0 0.08 306 1.0 0.29
Yes 21 0.33 (0.11, 0.94) 0.33 (0.09, 1.13) 48 0.66 (0.29, 1.51)
Palpate
No 44 1.0 0.27 92 1.0 0.07 1.0 0.04
Yes 120 1.49 (0.73, 3.01) 260 1.54 (0.97, 2.46) 1.67 (1.03, 2.71)
Suggest a lab
test
No 107 1.0 0.003 1.0 0.58 313 1.0 0.16
Yes 58 2.74 (1.42, 5.30) 1.77 (0.24, 13.17) 39 1.51 (0.82, 2.78)
Prescr syphilis
test
No 110 1.0 ,0.001 na 328 1.0 0.26
Yes 56 3.15 (1.61, 6.16) 26 1.57 (2.67, 3.72)
Prescr rhesus test
114 1.0 0.002 1.0 0.62 325 1.0 0.33
52 2.87 (1.45, 5.66) 0.59 (0.07, 4.81) 29 1.23 (0.78, 1.95)
Pay for
registration
No 105 1.0 ,0.001 1.0 0.62 176 1.0 0.07 1.0 0.40
Yes 61 3.26 (1.69, 6.29) 0.58 (0.07, 4.90) 178 1.80 (0.95, 3.41) 0.82 (0.50, 1.36)
Spent any money
No 1 na 62 1.0 0.05 1.0 0.07
Yes 165 292 2.23 (1.01, 4.93) 2.16 (0.91, 5.14)
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quantitative approaches and require the addition of qualitative
methods to further elucidate and explain quantitative findings.
These findings are explored and presented in the companion
paper (Webster et al Unpublished).
The delivery of ITNs was ineffective in the CSRef because ITNs
were out of stock, and relatively effective in the CSComs. In the
CSRef the ineffectiveness was due to a stock-out of ITNs during
the period of the survey. Although still below 80% in the CSComs
if the 2 CSCom with stock-outs of ITNs during the survey are
excluded from the analysis, the proportion of pregnant women
who were given an ITN on their first visit to a CSCom was 81.7%
and therefore using our definition of 80% of women completing
the process, the delivery was effective where ITNs were in-stock.
These data suggest that in this setting, if the health facilities have
stock of ITNs then, the delivery of them is effective. This assumes
that effectiveness of delivery of ITNs in the CSRef would mirror
that of the CSComs. This is the first time as far as we are aware
that the process effectiveness of direct delivery of ITNs through
ANC has been assessed, despite the acknowledged strategic
importance of this delivery channel for ITNs [15]. Other studies
have evaluated the outcomes at the population level of delivery of
ITNs through ANC [37], but have not assessed whether women
who attend ANC are offered or are given ITNs.
The estimations of design effect and intra-cluster correlation
were important in this study for reasons which can be divided into
those relating to internal validity of the study, and those relating to
interpretation of the findings for prioritising interventions, and for
optimising the design and targeting of these interventions. With
this study design and in this setting, clustering by health facility
varies greatly by indicator, elevated design effects have been
reported in other studies from Benin [38] and Ghana [39]. With a
high level of clustering the precision of the estimate for each
indicator is reduced as is the power to identify predictors of these
indicators. This may have resulted in some predictors being missed
in this study. Where the design effect and intra-cluster correlation
are high it would not be feasible in terms of the resources required,
to achieve the sample sizes needed for high precision on the
estimates using this study design. Increasing the number of
clusters, that is health facilities, and reducing the number of
observations within each facility would be a more operationally
feasible approach. However, given the magnitude of the design
effect on some of the indicators in this study, the increase in
clusters required would also not be achievable.
The calculation of design effects and intra-cluster correlation
however, provide some insight into the variability in implemen-
tation between health facilities which itself is important and
potentially useful information. For example, the two main
ineffective processes identified in this study, being given any SP
in ANC, and being given SP by DOT are very different in terms of
clustering by health facility, with clustering much higher for DOT.
This translates to there being a problem in pregnant women being
given any SP for some women in many of the health facilities,
whilst for being given SP by DOT; the problem is for most women
in some health facilities.
The study had several limitations. Non-participant structured
observations were the main tool for identifying ineffective
processes in this study. The Hawthorne effect is a well recognised
limitation of studies where behaviours are observed [40,41] and it
is possible that both the health workers and the pregnant women
involved in this study may have changed their behaviours. We
assumed that any change in behaviours was towards ‘best
behaviour’. The number of observations of some of the health
workers involved would have been sufficient for any behaviour
change to be likely to revert back to normal during the period of
the study [41], but not for the pregnant women. However, given
the poor findings on the cumulative and intermediate delivery
processes we do not believe that the Hawthorne effect is a
substantial worry in interpreting the findings of the study [42]. The
method used for enrolling pregnant women was based upon
feasibility of implementation of the study and was not technically
random. It is possible that the study was biased towards women
attending at certain times of day. However, this potential bias did
not impact upon the findings as time of attendance was not a
significant predictor in univariate analyses of receipt of being given
SP or an ITN. It is also possible that health worker behaviour on
the busy days chosen for implementation of this study may have
differed on less busy days. The study did not include data on the
timing since the last dose of IPTp-SP. International and national
guidelines state that there should be at least one month between
doses of IPTp-SP. In this study therefore we may have over-
estimated the health systems effectiveness of delivery of IPTp-SP if




Unadjusted Adjusted Unadjusted Adjusted
n OR (95% CI) p OR (95% CI) p n OR (95% CI) p OR (95% CI) p
Total money
spent
,500 79 1.0 ,0.001 1.0 0.02 69 1.0 0.19
500–999 51 4.89 (2.27, 10.49) 2.57 (0.66, 9.94) 80 2.27 (0.71, 7.33)
$1000 35 1.36 (0.60, 3.09) 0.56 (0.17, 1.86) 143 1.32 (0.62, 2.84)
Given ITN
No 165 na 203 1.0 0.04 1.0 0.17
Yes 1 151 2.68 (1.08, 6.67) 2.01 (0.69, 5.86)
Notes:
CSRef, Reference Health Center; CSCom, Community Health Cebter; OR, Odds Ratio; CI, Confidence Interval; n, number of events; PMTCT, Prevention of Mother to Child
Transmission; ANC, Antenatal Clinic; ITN, Insecticide Treated Net; Prescr, prescription; na, not applicable;
doi:10.1371/journal.pone.0067520.t006
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receiving the first dose. The inclusion of pregnant women with
symptoms of malaria in the denominator may have resulted in an
under-estimate of the effectiveness of delivery of IPTp-SP where it
is reasonable that these women should be treated for malaria using
the national case management guidelines. Assessment of predictors
of effectiveness may have been compromised where there were
stock-outs of ITNs.
Although we collected information on the health workers
involved in the delivery of ANC in the health facilities involved in
the study, the individual health workers observed at each stage of
ANC were not recorded, only the cadre. This was a limitation to
the inclusion of health worker factors in the assessment of
predictors of the effectiveness of intermediate processes. However,
cadre was not a significant predictor of being given IPTp-SP or an
ITN in the univariate analyses.
The strength of this study design is in allowing the in-depth
study of health systems delivery processes on the day that a
pregnant woman or patient attends the facility. It is not an
appropriate study design for providing estimates of the proportion
of pregnant women who are given one or more doses of IPTp-SP,
during their pregnancy, at the population level. Household surveys
are the most appropriate method for this. However, unlike in our
health facility study, household surveys rely on self reports from
pregnant women. A recent study from Uganda on the validity of
pregnant women’s reported behaviour on taking doses of IPTp-SP
showed such data to be inaccurate when assessed against plasma
levels of sulphadoxine [43].
Table 7. Unadjusted and adjusted predictors of being given









1 (poorest) 109 1.0 0.02 1.0 0.04
2 (very poor) 85 1.09 (0.41, 2.89) 1.16 (0.30, 4.48)
3 (poor) 84 0.37 (0.13, 1.10) 0.38 (0.10, 1.50)
4 (less poor) 41 0.29 (0.05, 1.70) 0.47(0.12, 1.81)
5 (least poor) 29 0.20 (0.02, 2.32) 0.45 (0.34, 5.97)
Process factors
Suggest a lab test
No 313 1.0 0.07 1.0 0.71
Yes 39 0.20 (0.03, 1.14) 1.67 (0.77, 36.48)
Presr syphilis test
No 328 1.0 0.03 1.0 0.16
Yes 26 0.07 (0.06, 0.78) 0.17 (0.01, 2.44)
Pay for consult
No 274 1.0 0.03 1.0 0.09
Yes 80 0.07 (0.01, 0.48) 0.12 (0.01, 1.52)
Money is spent
No 62 1.0 0.09 na
Yes 292 0.36 (0.11, 1.21)
Total money
spent
,500 69 1.0 0.004 1.0 0.01
500–999 80 12.57 (2.25, 70.06) 9.87 (1.28, 75. 71)
$1000 143 18.17 (5.10, 64.75) 12.17 (3.14,47.16)
Notes:
SP, Sulphadoxine-pyrimethamine; DOT, Direct Observed Treatment; n, number
of events; OR, Odds Ratio, CI, Confidence Interval; SES, Socio-economic Status;
Na, not available.
doi:10.1371/journal.pone.0067520.t007
Table 8. Unadjusted and adjusted predictors of being offered








1 (poorest) 61 1.0 0.008 1.0 0.002
2 (very poor) 54 0.55 (0.28, 1.06) 0.37 (0.14, 0.97)
3 (poor) 42 1.19 (0.26, 5.34) 5.74 (0.14, 229.2)
4 (less poor) 13 0.25 (0.53, 1.13) 0.06 (0.02, 0.17)
5 (least poor) 16 0.37 (0.02, 6.64) 3.15 (0.36, 27.21)
Process factors
Reason for visit
ANC 148 1.0 0.02 1.0 0.24
ANC & illness 40 0.48 (0.26, 0.89) 0.41 (0.08, 2.05)
Report malaria
No 159 1.0 0.07 1.0 0.04
Yes 30 0.56 (0.30, 1.07) 17.71 (1.24, 252.1)
Palpate
No 60 1.0 1.0 0.02
Yes 127 3.78 (1.63, 8.77) 0.006 4.62 (1.35, 15.75)
HIV at PMTCT
No 171 1.0 0.05 1.0 0.07
Yes 18 0.07 (0.01, 0.95) 0.04 (0.001, 1.47)
Pay for consult
No 154 1.0 0.04 1.0 0.01
Yes 35 0.11 (0.01, 0.85) 0.07 (0.01, 0.43)
Money spent on
travel
129 1.0 0.05 1.0 0.32
31 0.93 (0.18, 4.66) 0.96 (0.09, 10.14)
27 0.33 (0.14, 0.75) 0.14 (0.01, 1.91)
Total money
spent
,500 8 1.0 0.05 1.0 0.002
500–999 49 – –
$1000 117 5.8 (0.97, 34.57) 8.79 (2.74, 28.23)
Notes:
n, number of events; OR, Odds Ratio, CI, Confidence Interval; SES, Socio-
economic Status; ANC, Antenatal Clinic; HIV, Human Immunodeficiency Virus;
PMTCT, Prevention of Mother to Child Transmission.
doi:10.1371/journal.pone.0067520.t008
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The fieldworkers in this study were rigorously trained. There
are potential limitations to the use of this structured observation
method for assessing the effectiveness of delivery of interventions if
fieldworkers are not given rigorous training and the tools are not
extensively piloted. The two main reasons that the implementation
of this method is difficult are firstly that observers need to both
look and listen to what is happening in real time. And secondly,
unlike the administration of a questionnaire, observers are not able
to control the pace of the process if they are unsure of either an
action or a verbal interaction between the health provider and the
pregnant woman. Rigorous training and extensive piloting are key
to achieving quality implementation, together with tailored
structuring of the checklists to match the order of processes within
the health facilities.
The ultimate use of the findings of this study is to identify
reasons for reduced effectiveness in order to improve programme
delivery. Quantitative approaches however, are limited in their
ability to provide explanations of why a process is not working or
behaviour is not happening. These quantitative approaches are
also limited by their structured nature for example in the CSRef
whilst 39 women were observed to have been given tablets of SP
during consultation 4 of these women did not have the tablets on
exiting the health facility. The reasons for this may be either that
the women had taken the tablets after leaving ANC consultation
but before exiting the health facility, or that they disposed of the
tablets in the health facility. However, as these behaviours were
not pre-empted and included in the checklist or exit interview
questionnaire, the explanations were not captured. The limited
number of predictors of receiving IPTp-SP by DOT in this study is
another example where qualitative approaches are needed to
understand why this intermediate process was ineffective. For this
reason a qualitative study of the reasons for ineffective delivery was
explored from the perspectives of health workers involved and the
quantitative and qualitative findings used together to identify
disorders in implementation and offer practical solutions. These
findings are presented in a companion paper (Webster et al
Unpublished).
The time-frame and the resources required for such a research
study mean that whilst important for identifying implementation
problems and for identifying the areas which need further
illumination, this kind of approach is not applicable for routine
feedback to inform programme implementation and adjustments
required to improve its effectiveness. This requires the application
of findings from such research studies as this one to adapt routine
programmatic monitoring data at the district level for improving
the effectiveness of national and sub-national programmes.
In conclusion, in Segou District, the delivery of IPTp-SP was
ineffective whilst ITN delivery was ineffective at the district level
where ITNs were out of stock and effective in the community level
health facilities where ITNs were in stock. The specific interme-
diate processes which are effective may be identified through
quantitative analyses. Regression analyses may be used to
successfully identify major predictors of the effectiveness of these
processes, but requires additional qualitative analyses to further
illuminate factors influencing the delivery processes. Adaptation of
this methodology to routine monitoring systems is required to use
the opportunity presented by this approach to influence successful
uptake of IPT-SP and other interventions at the programmatic
level.
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Table 9. Design effect and intra cluster correlation of delivery processes amongst the CSRef plus CSComs and the CSComs.





Attended ANC 100 – – 100 (2) – –
Given SP during
consultation
68.0 (40.6–78.9) 2.86 0.033 60.9 (40.6–78.9) 8.08 0.139
Given 3 tablets 97.1 (92.3–100) 1.49 0.009 97.5 (90–100) 1.4 0.008
Took SP by DOT 33.1 (0–98.3) 21.11 0.353 25.3 (0–98.3) 26.1 0.492
Told to take 3 tablets 93.4 (0 100) 1.07 0.001 93.4 (0–100) 1.07 0.001
Has SP tablets on exit 61.8 (1.8–95.5) 18.22 0.302 69.1 (1.8–95.4) 21.2 0.396
Report correctly how
to take tablets on exit
98.5 (95.1–100) 0.83 20.003 98.1 (95.1–100) 0.54 20.008
Know to take 3 tablets
& has tablets on exit
or took SP by DOT
99.0 (95.2–100) 1.0 0.0001 98.6(95.2–100) 0.81 20.004
Told when to return
for next dose
14.8 (0–30) 2.53 0.027 15.4 (0–30) 1.87 0.018
Told to return in 4 to
5 weeks
79.75 (0–100) 0.58 20.007 82.7 (0 100) 0.67 20.006
Offered an ITN 42.59 (0–67.86) 10.33 0.164 30.7 (0–67.9) 27.7 0.524
Notes:
CSCom, Community Health Centre; CSRef, Reference Health Centre; N = sample size; DE, Design Effect; ICC, intra-class correlation, SP, Sulphadoxine-pyrimethamine;
DOT, Direct Observed Treatment; ITN, Insecticide Treated Nets.
doi:10.1371/journal.pone.0067520.t009
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